|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US6727405B1
(en)
|
1986-04-09 |
2004-04-27 |
Genzyme Corporation |
Transgenic animals secreting desired proteins into milk
|
|
US5215909A
(en)
|
1986-06-18 |
1993-06-01 |
Yeda Research & Development Co., Ltd. |
Human cholinesterase genes
|
|
US5322775A
(en)
|
1986-06-30 |
1994-06-21 |
Pharmaceutical Proteins Ltd. |
Peptide production
|
|
EP0279582A3
(en)
|
1987-02-17 |
1989-10-18 |
Pharming B.V. |
Dna sequences to target proteins to the mammary gland for efficient secretion
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
US5750172A
(en)
|
1987-06-23 |
1998-05-12 |
Pharming B.V. |
Transgenic non human mammal milk
|
|
FR2649991B2
(fr)
|
1988-08-05 |
1994-03-04 |
Rhone Poulenc Sante |
Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
|
|
IL89703A
(en)
|
1989-03-21 |
2001-10-31 |
Yissum Res Dev Co |
Polynucleotide encoding human acetylcholinesterase, vectors comprising said polynucleotide, cells transformed by said vectors, enzyme produced by said transformed cell, and uses thereof
|
|
US5227301A
(en)
|
1989-11-03 |
1993-07-13 |
The 501 Institution For The Advancement Of Learning (Mcgill University) |
Immortalized bovine mannary epithelial cell line
|
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
|
US5831141A
(en)
|
1991-01-11 |
1998-11-03 |
United States Of America As Represented By The Department Of Health And Human Services |
Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter
|
|
IL101600A
(en)
|
1992-04-15 |
2000-02-29 |
Yissum Res Dev Co |
Synthetic partially phosphorothioated antisense oligodeoxynucleotides and pharmaceutical compositions containing them
|
|
US6110742A
(en)
|
1992-04-15 |
2000-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Synthetic antisense oligodeoxynucleotides targeted to AChE
|
|
ES2146648T3
(es)
|
1993-03-09 |
2000-08-16 |
Genzyme Corp |
Procedimiento de aislamiento de proteinas de la leche.
|
|
US5610053A
(en)
|
1993-04-07 |
1997-03-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
|
|
DE4326665C2
(de)
|
1993-08-09 |
1995-07-13 |
Biotest Pharma Gmbh |
Verfahren zur Sterilfiltration von Milch
|
|
US6025183A
(en)
|
1994-02-28 |
2000-02-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Transgenic animal assay system for anti-cholinesterase substances
|
|
US5932780A
(en)
|
1994-02-28 |
1999-08-03 |
Yissum Research Development Company Of Hebrew University Of Jerusalem |
Transgenic non-human animal assay system for anti-cholinesterase substances
|
|
US6204431B1
(en)
|
1994-03-09 |
2001-03-20 |
Abbott Laboratories |
Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
|
|
US5807671A
(en)
|
1995-01-09 |
1998-09-15 |
Yissum Research Development Company Of Hebrew University Of Jerusalem |
Method of screening for genetic predisposition to anticholinesterase therapy
|
|
US5780009A
(en)
|
1995-01-20 |
1998-07-14 |
Nexia Biotechnologies, Inc. |
Direct gene transfer into the ruminant mammary gland
|
|
US6001625A
(en)
|
1995-05-19 |
1999-12-14 |
The United States Of America As Represented By The Secretary Of The Army |
Site-directed mutagenesis of esterases
|
|
IL115873A0
(en)
|
1995-11-03 |
1996-01-31 |
Peri Dev Applic 1985 Ltd |
Transgenic protein production
|
|
US6326139B1
(en)
|
1996-01-11 |
2001-12-04 |
Yissum Research Development Company Of Hebrew University Of Jerusalem |
Method of screening for genetic predisposition to anticholinesterase therapy
|
|
US6268487B1
(en)
|
1996-05-13 |
2001-07-31 |
Genzyme Transgenics Corporation |
Purification of biologically active peptides from milk
|
|
US20020184655A1
(en)
|
1997-12-01 |
2002-12-05 |
Henryk Lubon |
Methods for the degradation and detoxification of organic material using urine produced by transgenic animals and related transgenic animals and proteins
|
|
US7157615B2
(en)
|
1998-03-17 |
2007-01-02 |
Nexia Biotechnologies, Inc. |
Production of biofilaments in transgenic animals
|
|
AU755334C
(en)
|
1998-08-25 |
2004-02-26 |
University Of Washington |
Rapid quantitative analysis of proteins or protein function in complex mixtures
|
|
EP1112353A2
(en)
|
1998-09-16 |
2001-07-04 |
Nexia Biotechnologies, Inc. |
Recombinant protein production in urine
|
|
US6580017B1
(en)
|
1998-11-02 |
2003-06-17 |
Genzyme Transgenics Corporation |
Methods of reconstructed goat embryo transfer
|
|
AU1621900A
(en)
|
1998-11-13 |
2000-06-05 |
New York University |
Transgenic animals as urinary bioreactors for the production of protein in the urine, recombinant dna construct for kidney-specific expression, and method of using same
|
|
CA2354638C
(en)
|
1999-01-06 |
2013-03-19 |
Atlantic Biopharmaceuticals, Inc. |
Expression of secreted human alpha-fetoprotein in transgenic animals
|
|
US7297680B2
(en)
*
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
ES2209915T3
(es)
|
1999-04-26 |
2004-07-01 |
U.S. Army Medical Research And Materiel Command |
Esponjas de destoxificacion op de actuacion diferencial.
|
|
IL131707A0
(en)
|
1999-05-31 |
2001-03-19 |
Yissum Res Dev Co |
Acetylcholinesterase-derived peptides and uses thereof
|
|
US6770799B2
(en)
|
2000-03-17 |
2004-08-03 |
Thompson Boyce Plant Res |
Expression of recombinant human acetylcholinesterase in transgenic plants
|
|
US6946134B1
(en)
|
2000-04-12 |
2005-09-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
EP1803730A1
(en)
|
2000-04-12 |
2007-07-04 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US7070973B2
(en)
|
2000-12-26 |
2006-07-04 |
Board Of Regents Of The University Of Nebraska |
Butyrylcholinesterase variants and methods of use
|
|
IL142875A
(en)
|
2001-04-30 |
2009-08-03 |
Avigdor Shafferman |
PEG-linked cholinesterases for the detoxification of circulating organophosphorus
|
|
AR033903A1
(es)
|
2001-05-21 |
2004-01-07 |
Inhale Therapeutic Syst |
Una composicion de insulina modificada quimicamente para la administracion pulmonar
|
|
EP2172552A3
(en)
*
|
2001-10-11 |
2010-07-21 |
Merck Sharp & Dohme Corp. |
Recombinant nucleic acids comprising regions of AD6
|
|
AU2002365202A1
(en)
|
2001-11-09 |
2003-09-02 |
Entremed, Inc. |
Synthetic genes for malarial proteins and methods of use
|
|
WO2003054182A2
(en)
|
2001-12-21 |
2003-07-03 |
Nexia Biotechnologies, Inc. |
Production of butyrylcholinesterases in transgenic mammals
|
|
BR0316865A
(pt)
*
|
2002-12-04 |
2005-10-25 |
Applied Molecular Evolution |
Variante de butirilcolinesterase, ácido nucleico, e, métodos para converter um derivado de camptotecina a um inibidor de topoisomerase, e para tratar câncer
|
|
EP1670950A2
(en)
|
2003-10-10 |
2006-06-21 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Method and kit for assessing anxiety or disposition thereto in a subject
|
|
EP2053409A1
(en)
|
2003-11-20 |
2009-04-29 |
F. Hoffmann-La Roche Ag |
Specific markers for metabolic syndrome
|
|
US20090169520A1
(en)
|
2004-01-09 |
2009-07-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compounds, Pharmaceutical Compositions and Therapeutic Methods of Preventing and Treating Diseases and Disorders Associated With Amyloid Fibril Formation
|
|
WO2007011390A2
(en)
|
2004-10-09 |
2007-01-25 |
Government Of The United States As Represented By The Secretary Of The Army |
Large-scale production of human serum butyrylcholinesterase as a bioscavenger
|
|
US9062321B2
(en)
|
2004-12-01 |
2015-06-23 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Codon-optimized polynucleotides encoding human butyrylcholinesterase and plant expression systems therof
|
|
US20090249503A1
(en)
|
2004-12-06 |
2009-10-01 |
Bolder Biotechnology, Inc. |
Enzyme conjugates for use as detoxifying agents
|
|
IL169377A
(en)
|
2005-06-23 |
2012-09-24 |
Avigdor Shafferman |
Uniformly conjugated serine hydrolases
|
|
JP5250850B2
(ja)
*
|
2006-06-29 |
2013-07-31 |
ディーエスエム アイピー アセッツ ビー．ブイ． |
改善されたポリペプチド発現を達成する方法
|
|
CA2659809A1
(en)
|
2006-08-04 |
2008-02-14 |
Pharmathene Inc. |
Long half-life recombinant butyrylcholinesterase
|
|
WO2009024567A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Glaxo Group Limited |
Production method
|
|
US7846428B2
(en)
*
|
2007-10-05 |
2010-12-07 |
Merial Limited |
Articular cartilage gene therapy with recombinant vector encoding BMP-7
|
|
AU2010340358B2
(en)
|
2009-12-21 |
2014-07-24 |
Pharmathene, Inc. |
Recombinant butyrylcholinesterases and truncates thereof
|